Link share

Top Biopharmas Strengthens Medical Engagement with Veeva Link Scientific Awareness

Big companies take advantage real-time insights into scientific voice share and product sentiment to fuel more relevant medical communications

PLEASANTON, Calif., November 23, 2022 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that three of the top ten biopharmaceutical companies are now using the newly released Veeva Link Scientific Awareness to gain real-time insights into consumer awareness and sentiment. products. Veeva Link Scientific Awareness provides key success metrics across scientific, digital, and social channels to help medical teams optimize product strategy and effectively educate the scientific and medical community about different treatments.

“Medical teams are moving from volume-based activity measures to value-driven standards that show the external impact of medical activities within the scientific and clinical community,” said Zijian Zhao, Global Head of Medical Portfolio Strategy at Novartis. “Veeva Link Scientific Awareness helps us quickly assess product awareness across all channels to drive engagements that strengthen relationships and improve patient service.”

Veeva Link Scientific Awareness is part of the Veeva Link family of products, a modern data platform that combines intelligent software automation with human curation to ensure accuracy and depth. This helps Veeva Link deliver real-time information in a growing number of areas, including sales, medical, marketing, and clinical. Available in 87 countries, the application analyzes data from more than 300,000 medical conferences and 100 million social publications, organized by more than 1,000 specialists and validated by more than 100 doctors.

“Real-time intelligence is key to understanding the evolving healthcare ecosystem and tailoring engagements with scientific experts to meet their specific needs across all therapeutic areas,” says Kilian Weiss, CEO of Veeva Link. “Veeva Link Scientific Awareness helps medical teams guide more effective communications that deepen product understanding so patients and physicians are better informed in today’s on-demand digital world.

At the Veeva Commercial Summit Europe in Madrid of November 28-30, 2022, Novartis and others will share how they are leveraging Link Scientific Awareness in their organizations to increase expert engagement. Life science industry professionals can register at

Further information
To learn more about Veeva Link Scientific Awareness, visit:
Connect with Veeva on LinkedIn:

About Veeva systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a public benefit company, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit

Veeva forward-looking statements
This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits of using our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this press release and we undertake no obligation to update these statements. There are numerous risks that could adversely impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (a summary of risks that may impact our business can be found on pages 39 and 40), and in our filings with the SEC, which you can access at

Alison Borris
Veeva Systems
[email protected]

SOURCE Veeva Systems